Filing Details

Accession Number:
0001209191-13-018116
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-22 18:40:21
Reporting Period:
2013-03-20
Filing Date:
2013-03-22
Accepted Time:
2013-03-22 18:40:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1009356 Salix Pharmaceuticals Ltd SLXP Pharmaceutical Preparations (2834) 943267443
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1301715 A Mark Sirgo 606 Wayne Street
Raleigh NC 27608
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-03-20 3,000 $50.05 28,955 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was pursuant to a Rule 10b5-1 Sales Plan dated December 3, 2012, which is intended to comply with Rule 10b5-1.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.03 to $50.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.